Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pasithea Therapeutics Corp.

0.8700
+0.03904.69%
Post-market: 0.87000.00000.00%18:36 EDT
Volume:1.04M
Turnover:885.76K
Market Cap:5.68M
PE:-0.07
High:0.9000
Open:0.8850
Low:0.8223
Close:0.8310
Loading ...
Dec 14, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 14, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 20, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 12, 2022

Major Issues Report

8-K - Current report
Sep 21, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 20, 2022

Major Issues Report

8-K - Current report
Sep 06, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 29, 2022

Major Issues Report

8-K/A [Amend] - Current report
Aug 15, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 28, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 29, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 27, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 27, 2022

Major Issues Report

8-K/A [Amend] - Current report
Jun 24, 2022

Major Issues Report

8-K - Current report
Jun 24, 2022

Major Issues Report

8-K/A [Amend] - Current report
Jun 22, 2022

Major Issues Report

8-K - Current report